March marks Ovarian Cancer Awareness Month, a crucial time to highlight the challenges of this disease and reflect on the progress made in ovarian cancer research across the UK. Advances in diagnostics, treatment innovation, and regulatory support have laid a foundation for improved outcomes and renewed hope for patients and their families.

Understanding ovarian cancer

Ovarian cancer is one of the most prevalent gynaecological cancers, with around 7,500 new cases diagnosed each year in the UK. Common symptoms—such as persistent bloating, abdominal pain, feeling full quickly, and changes in bowel habits—can be subtle and easily missed. This often leads to late-stage detection and a five-year survival rate of just 46%.

Breakthroughs in ovarian cancer research and funding

The UK has emerged as a leader in ovarian cancer research, with notable contributions from national organisations and academic institutions:

  • Ovarian Cancer Action: Founded in 2005, this charity funds critical scientific research and supports the Ovarian Cancer Action Research Centre at Hammersmith Hospital—one of Europe’s largest dedicated research hubs.

  • OvarianVax: At the University of Oxford, researchers are developing the world’s first ovarian cancer vaccine. This promising therapy, backed by Cancer Research UK, aims to train the immune system to detect and target early-stage cancer cells, particularly in individuals with BRCA gene mutations. The vaccine is currently undergoing clinical trials.

For more on the impact of charities funding research like this, see Cancer Research UK’s research strategy.

Regulatory developments supporting innovation

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has accelerated access to novel therapies through:

  • Fast-track approvals: Speeding up the availability of effective new treatments to patients.

  • Companion diagnostics: Supporting precision medicine by authorising diagnostic tools that identify which patients are most likely to benefit from a specific treatment.

These initiatives reinforce the importance of regulation in enabling safe and effective innovation in ovarian cancer care.

Looking forward: challenges and opportunities

While progress in ovarian cancer research is clear, challenges remain—particularly in early diagnosis and long-term treatment efficacy. A continued, coordinated effort among scientists, clinicians, regulatory bodies, and patient advocates will be critical in driving further improvements.

This Ovarian Cancer Awareness Month, it’s time to celebrate breakthroughs and recommit to the mission of advancing research, expanding treatment options, and ultimately, finding a cure.

Let’s chat about the issues affecting you. Click here to get in touch.

Back to News + Insights